I forgot to unfollow it. And I do have trouble keeping my mouth shut.
You know what I find interesting is you posted a blog that had a view was derisive of the non gmo project and followers.
You didn’t submit any proof that their view was wrong. You were having fun. Nothing terribly wrong with that.
Glacial seems opposed to the politicness of the non gmo project. But considering the other side is just as political I fail to see the problem.
The posts I pulled from acknowlged a risk for an ige response due to the corn derived dextrose in them. The dextrose itself was not in question.
That is what I found interesting. That and many people do not have that severe an allergy to corn. I agree that is extremely rare. Must be hard to live with. What isnt pertinent to those two cases and not mentioned is the igg and iga sensitivities that also respond but would not be an emergency on an operating table. Makes life difficult but one is not threatened by immediate death so not note worthy. I didn’t feel it was necessary to point that out but apparently it is.
As to lack of proof I question whether or not the burden of proof is on me. The facts being there isn’t enough proof in either direction. Thus the controversy.
In the words of the pew foundation on allergies and biotechnology.
The ability of biotechnology to move genes from one organism into another creates the possibility of introducing allergenic proteins into foods that would not ordinarily contain them. When the source of an introduced gene is a food known to have allergenic potential, product developers can readily test the genetically modified food to see if the allergenic properties have indeed been carried over into the new variety. Under current Food and Drug Administration (FDA) guidelines, a genetically modified food must be labeled if the new variety contains an allergenic substance that a consumer would not ordinarily expect to find in that food. The more difficult issue is posed by the introduction of novel proteins that have not been previously in the food supply. Without prior exposure data, the ability to predict the potential of the protein to cause an allergic reaction is very limited. This problem became readily apparent in the recent recall of food products that had been inadvertently contaminated with StarLink, a genetically modified corn variety that had not been approved for human food by the Environmental Protection Agency (EPA) because it could not be shown that the novel protein in StarLink was not an allergen. With new genetically modified foods under development, some of which could involve novel proteins, what is being done to improve scientists’ ability to understand and predict the allergenic potential of new proteins? This is a key question for food safety regulators. To find the answer to this question, the Pew Initiative on Food and Biotechnology commissioned Dr. Lynn Goldman, Professor of Public Health at Johns Hopkins University, to conduct a study of ongoing federal research efforts. While the report finds a variety of food allergy research projects scattered over several federal agencies, Dr. Goldman and her co-author Dr. Luca Bucchini conclude that both the level of funding and the type of research being funded are unlikely to substantially advance scientific knowledge on this key question and therefore will not address fully the needs of food safety regulators. Given the millions of dollars invested in the development of new biotechnology food products, and the importance of maintaining consumer confidence in the safety of the food supply, increased research attention to this issue appears warranted.
Back to me. We may both not have a leg to stand on as facts go. But until you face or know someone intimately that faces the challenges on health a food allergy has and feels there is enough reason to question the safety of biotechnology in the change in their health or until there is definitive proof one way the other your opinion is as uninformed as my own, in a different manner of course.